7Rolf vornhagen, Bodo plachter, Walter inderer, et al. Early Serodiagnosis of Acute Human Cytomegalovirus Infection by Enzyme- Linked Immunosorbent Assay Using Recombinant Antigens[J]. Journal of Clinical Microbiology, 1994, (4) : 981 - 986.
8Roll Vornhagen, Walter Hinderer, et al. The DNA - Binding Protein pUL57 of Human Cytomegalovirus Is a Major Target Antigen for the Immunoglobulin M Antibody Response dur ing Acute Infection[J]. Journal of Clinical Microblolgy, 1995, (7) ,1927- 1930.
9G. T. Maine, R. Stricker, M. Sehuler, J. Spesard, et al. Devel opment and Clinical Evaluation of a Recombinant - Antigen - Based Cytomegalovirus Immunoglobulin M Automated Im- munoassay Using the Abbott AxSYM Analyzer[J]. Journal of Clinical Microbiology, 2000, (4) : 1476 - 1481.
10Greijer, A. E, , J. M. G. van de Crommert, S. J. C. Stevens, and J. M. Middeldorp. Molecular fine - specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic - peptide - based serodiagnostic assays[J]. J Clin Microbiol,1999,37:179- 188.
2[1]Rubin RH,Ikonen T,Gummet JF,et al.The therapeutic prescription for the organ transplant recipient:the linkage of immunosuppression and antimicrobial strategies.Transpt Infect Dis,1999,1:29-32
3[2]Vilacian JS,Paya CV.Prevention of infections in slolid organ transplant recipients.Transpt Infect Dis,1999,1:50-53
4[3]Fishman JA,Rubin RH.Infection in organ-transplante recipients.New Eng J Med,1998,338(24):1741-1745
5[4]Delmonico FL,Snydman DR.Organ dornor screeing for infectious diseases.Transplantation,1998,65:603-606
6[5]Rubin RH,Wolfson JS,Cosimi AB,et al.Infection in the renal transplant patient.Am J med,1981,70:405-411
7[6]Fietzw E,Prosch S,Reinke P,et al.Cytomegalovirus infection in transplant recipients:the role of tumor necrosis factor.Transplantation,1994,58:675-680
3Johnson JM, Anderson BL Cytomegalovirus: should we screen pregnant women for primary infection? J] . Am J Perinatol, 2013, 30 (2) : 121 - 124.
4Yamamoto AY, Castellucci RA, Aragon DC, et al. Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection [ J] . Epidemiol Infect, 2012, 3 (1): 1-5.
5Lazzarotto T, Guerra B, Gabrielli L, et al. Update on the pre- vention, diagnosis and management of cytomegalovirus infection during pregnancy [J] . Clin Microbiol Infect, 2011, 17 (9) : 1285 - 1293.
6De Clercq E.Looking back in 2009at the dawning of antiviral therapy now 50years ago an historical perspective[J].Adv Virus Res,2009,73(1):1-53.
7Hu J,Zhao H,Huang Y,et al.Prospective study of postransplant poluomaviru Infection in renal transplant recipients[J].Exp Clin Transplant,2011,9(3):175-180.
8De Clercq E. Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective [ J ]. Adv Virus Res,2009,73 (1) :1 -53.
9Hu J, Zhao H, Huang Y, et al. Prospective study of postransplant poluo- maviru Infection in renal transplant recipients[ J]. Exp Clin Transplant, 2011,9(3) :175 - 180.
